000 01971cam  2200385za 4500
0019.840128
003CaOODSP
00520221107151752
007cr |||||||||||
008170721m20182013quc    #ob   f000 0 eng d
040 |aCaOODSP|beng
041 |aeng|bfre
043 |an-cn---
0861 |aP29-191-001-2013E-PDF
24500|aResearch ethics oversight of biomedical clinical trials |h[electronic resource] / |cprepared by the Canadian General Standards Board ; approved by the Standards Council of Canada.
250 |aWithdrawn
260 |aGatineau : |bCanadian General Standards Board, |c2013, 2018.
300 |a1 v. (various pagings)
4901 |aNational standard of Canada ; |vno. 191.1-2013
500 |a"May 2013."
500 |a"Withdrawal July 2018."
500 |a"Experience and excellence"--Cover.
500 |aIssued also in French under title: Surveillance de l'éthique de recherches comportant des essais cliniques biomédicaux.
504 |aIncludes bibliographical references.
520 |a"This National Standard of Canada applies to Research Ethics Boards (REBs) that evaluate applications for ethical acceptability. If an REB grants ethics approval to conduct biomedical clinical trials, it will provide research ethics oversight of biomedical clinical trials that are subject to the Food and Drugs Act and applicable Regulations"--Scope.
546 |aText in English, withdrawal in English and French.
69207|2gccst|aResearch
69207|2gccst|aEthics
69207|2gccst|aStandards
7102 |aStandards Council of Canada.
7102 |aCanadian General Standards Board.
77508|tSurveillance de l'éthique de recherches comportant des essais cliniques biomédicaux |w(CaOODSP)9.840131
830#0|aNational standard of Canada ;|vno. 191.1-2013.|w(CaOODSP)9.507848
85640|qPDF|s953 KB|uhttps://publications.gc.ca/collections/collection_2017/ongc-cgsb/P29-191-001-2013-eng.pdf